UMC Stock Overview
An investment holding company, develops, manufactures, markets, and distributes medical devices and consumables in Malaysia, the Asia Pacific, the Americas, Europe, the Middle East, Africa, and Oceania. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 5/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
UMediC Group Berhad Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | RM 0.62 |
| 52 Week High | RM 0.77 |
| 52 Week Low | RM 0.56 |
| Beta | 0.12 |
| 1 Month Change | 3.33% |
| 3 Month Change | 1.64% |
| 1 Year Change | -11.43% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 40.91% |
Recent News & Updates
Recent updates
UMediC Group Berhad's (KLSE:UMC) Returns On Capital Not Reflecting Well On The Business
Nov 11
UMediC Group Berhad (KLSE:UMC) Hasn't Managed To Accelerate Its Returns
Aug 05We Think You Should Be Aware Of Some Concerning Factors In UMediC Group Berhad's (KLSE:UMC) Earnings
Jun 17UMediC Group Berhad's (KLSE:UMC) Earnings Are Of Questionable Quality
Dec 18Revenue Downgrade: Here's What Analysts Forecast For UMediC Group Berhad (KLSE:UMC)
Dec 12Some Investors May Be Worried About UMediC Group Berhad's (KLSE:UMC) Returns On Capital
Aug 11Robust Earnings May Not Tell The Whole Story For UMediC Group Berhad (KLSE:UMC)
Mar 13Is There An Opportunity With UMediC Group Berhad's (KLSE:UMC) 21% Undervaluation?
Nov 25Shareholder Returns
| UMC | MY Healthcare | MY Market | |
|---|---|---|---|
| 7D | -6.1% | -1.2% | -1.0% |
| 1Y | -11.4% | 20.2% | 10.0% |
Return vs Industry: UMC underperformed the MY Healthcare industry which returned 20.2% over the past year.
Return vs Market: UMC underperformed the MY Market which returned 10% over the past year.
Price Volatility
| UMC volatility | |
|---|---|
| UMC Average Weekly Movement | 3.9% |
| Healthcare Industry Average Movement | 3.9% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in MY Market | 10.5% |
| 10% least volatile stocks in MY Market | 2.5% |
Stable Share Price: UMC has not had significant price volatility in the past 3 months compared to the MY market.
Volatility Over Time: UMC's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2021 | n/a | Taw Lim | www.umedic.com.my |
UMediC Group Berhad, an investment holding company, develops, manufactures, markets, and distributes medical devices and consumables in Malaysia, the Asia Pacific, the Americas, Europe, the Middle East, Africa, and Oceania. The company operates nursing homes and healthcare centers, and other related services; markets and distributes laboratory equipment and consumables; and provides after-sales services. It offers HYDROX prefilled humidifiers and nebulizers; AIRDROX inhaler spacers; FLEXIDROX water for inhalation bag; and products such as hospital furniture, life-support solution, MR compatible monitoring solution, oxygen therapy and suction solution, patient monitoring system, resuscitation care, ultrasound solution, women and childcare, critical care solution, and anaesthesia solution.
UMediC Group Berhad Fundamentals Summary
| UMC fundamental statistics | |
|---|---|
| Market cap | RM 231.82m |
| Earnings (TTM) | RM 8.95m |
| Revenue (TTM) | RM 53.10m |
25.9x
P/E Ratio4.4x
P/S RatioIs UMC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| UMC income statement (TTM) | |
|---|---|
| Revenue | RM 53.10m |
| Cost of Revenue | RM 29.97m |
| Gross Profit | RM 23.13m |
| Other Expenses | RM 14.18m |
| Earnings | RM 8.95m |
Last Reported Earnings
Oct 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.024 |
| Gross Margin | 43.55% |
| Net Profit Margin | 16.85% |
| Debt/Equity Ratio | 0.9% |
How did UMC perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/21 00:54 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/10/31 |
| Annual Earnings | 2024/07/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
UMediC Group Berhad is covered by 6 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Ken-Wern Lim | Affin Hwang Investment Bank |
| Siu Li Chua | Hong Leong Investment Bank Berhad |
| Chee Siang | Hong Leong Investment Bank Berhad |